William E. Kennard - 16 Jun 2026 Form 4 Insider Report for METLIFE INC (MET)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Jun 2026, 16:13:02 UTC
Prior SEC filing
11 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Taylor McInerney Jansen, Attorney-in-fact

Key filing fact

William E. Kennard filed Form 4 for METLIFE INC (MET) on 18 Jun 2026.

Key facts

  • This page summarizes William E. Kennard's Form 4 filing for METLIFE INC (MET).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Jun 2026, 16:13.

Change

  • Previous filing in this sequence was filed on 11 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001198236 Primary reporting owner

Kennard William E

Relationship
Director
Address
METLIFE, INC., 200 PARK AVENUE, NEW YORK
Signature
/s/ Taylor McInerney Jansen, Attorney-in-fact
Signature date
18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MET transaction

Common Stock

Award

Transaction value
Shares
+587
Change %
+1.3%
Price
$87.40*
Shares after
47,410
Date
16 Jun 2026
Ownership
Direct
Footnotes
F1
MET holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10
Date
16 Jun 2026
Ownership
By the MetLife Policyholder Trust
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Footnote F2

Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .